Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGM - Delayed Quote USD

Nurix Therapeutics, Inc. (NRIX)

Compare
12.15
-0.40
(-3.19%)
At close: March 28 at 4:00:00 PM EDT
12.15
0.00
(0.00%)
After hours: March 28 at 4:20:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
11/30/2024
11/30/2023
11/30/2022
11/30/2021
Total Revenue
54,549
54,549
76,987
38,627
29,750
Operating Expense
267,576
267,576
232,050
222,494
147,636
Operating Income
-213,027
-213,027
-155,063
-183,867
-117,886
Net Non Operating Interest Income Expense
19,728
19,728
11,115
3,507
823
Pretax Income
-193,299
-193,299
-143,948
-180,360
-117,063
Tax Provision
270
270
--
--
131
Net Income Common Stockholders
-193,569
-193,569
-143,948
-180,360
-117,194
Diluted NI Available to Com Stockholders
-193,569
-193,569
-143,948
-180,360
-117,194
Basic EPS
-2.88
--
-2.65
-3.71
-2.73
Diluted EPS
-2.88
--
-2.65
-3.71
-2.73
Basic Average Shares
67,120.27
--
54,337.90
48,607.99
42,895.38
Diluted Average Shares
67,120.27
--
54,337.90
48,607.99
42,895.38
Total Operating Income as Reported
-213,027
-213,027
-155,063
-183,867
-117,886
Total Expenses
267,576
267,576
232,050
222,494
147,636
Net Income from Continuing & Discontinued Operation
-193,569
-193,569
-143,948
-180,360
-117,194
Normalized Income
-193,569
-193,569
-143,948
-180,360
-117,194
Interest Income
19,728
19,728
11,115
3,507
823
Net Interest Income
19,728
19,728
11,115
3,507
823
EBIT
-213,027
-213,027
-155,063
-183,867
-117,886
EBITDA
-196,599
-196,599
-141,409
-173,059
-111,804
Reconciled Depreciation
16,428
16,428
13,654
10,808
6,082
Net Income from Continuing Operation Net Minority Interest
-193,569
-193,569
-143,948
-180,360
-117,194
Normalized EBITDA
-196,599
-196,599
-141,409
-173,059
-111,804
Tax Rate for Calcs
0
0
--
--
0
11/30/2021 - 7/24/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KYMR Kymera Therapeutics, Inc.
29.62
-1.92%
 
ORIC ORIC Pharmaceuticals, Inc.
6.14
-2.38%
 
BCYC Bicycle Therapeutics plc
8.97
-2.39%
 
NUVL Nuvalent, Inc.
73.05
-0.77%
 
ACLX Arcellx, Inc.
67.96
-0.80%
 
VRDN Viridian Therapeutics, Inc.
14.44
-1.57%
 
OLMA Olema Pharmaceuticals, Inc.
4.1100
-2.14%
 
XNCR Xencor, Inc.
11.23
-2.43%
 
RLAY Relay Therapeutics, Inc.
2.7200
-9.03%
 
MLTX MoonLake Immunotherapeutics
39.86
+0.05%